Log In
BCIQ
Print this Print this
 

Cyclooxygenases (COX)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Cyclooxygenases (COX)

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 12 Marketed, 3 Marketed, 1 Marketed, 1 Marketed, 8 Approved, 1 Approved, 1 Approved, 1 Registration, 1 Phase III, 1 Phase III, 1 Phase II, 2 Phase II, 1 Phase II, 1 Phase I, 1 Phase I, 2 Phase I, 1 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Autoimmune

-

-

1

-

1

1

8

Cardiovascular

-

-

-

-

-

-

1

Dermatology

-

1

1

-

-

-

1

Gastrointestinal

-

-

-

1

-

-

-

Inflammation

-

1

-

-

-

-

3

Neurology

1

2

2

1

-

1

12

Ophthalmic

-

1

-

-

-

1

2




 Products Targeting Cyclooxygenases (COX)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

25

$165,241.4M

$164,887.7M

$64.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today